We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Comen Medical

Download Mobile App




Illustration

AI Models Can Predict Individual Risk of Hospitalization for COVID Using HIE Data

A study has demonstrated how clinical data from healthcare systems can be used to better inform public health decision-making. More...
27 Jan 2022
Illustration

Machine Learning-Enabled COVID-19 Prognostic Tool Supports Clinical Decision-Making for Emergency Department Discharge

Researchers who evaluated the real-time performance of a machine learning (ML)-enabled, COVID-19 prognostic tool found that it supported clinical decision-making for emergency department discharge at hospitals. More...
26 Jan 2022
Illustration

Lung Ultrasound as Good as Chest X-Ray for COVID-19 Diagnosis and Management

A retrospective multicenter study by researchers from Italy, Portugal and Spain has found lung ultrasound (LUS) to be as good as chest X-ray (CXR) for accurate COVID-19 diagnosis. More...
25 Jan 2022
Illustration

Early Blood Testing for Viral Measurement During Initial Diagnosis Can Predict Long COVID

Researchers have identified several factors that can be measured using blood tests at the initial point of COVID-19 diagnosis that anticipate if a patient is likely to develop long COVID. More...
24 Jan 2022
Illustration

Pfizer’s Novel COVID-19 Oral Treatment Demonstrates In Vitro Efficacy Against Omicron Variant

Pfizer Inc. (New York, NY, USA) has shared the results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active main protease (Mpro) inhibitor of PAXLOVID (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), is maintained against the SARS-CoV-2 variant Omicron. More...
20 Jan 2022
Image: Proteomics core facility at Charité University hospital Berlin (Photo courtesy of Johannes Hartl, Charité)

Machine Learning Model Uses Blood Tests to Predict Survival of Critically Ill COVID-19 Patients

A single blood sample from a critically ill COVID-19 patient can be analyzed by a machine learning model which uses blood plasma proteins to predict survival, weeks before the outcome, according to a new study. More...
20 Jan 2022
Image: Groundbreaking AI Technology Accurately Diagnoses COVID-19 Using Chest X-Rays in Minutes (Photo courtesy of University of the West of Scotland)

Groundbreaking AI Technology Accurately Diagnoses COVID-19 Using Chest X-Rays in Minutes

A pioneering artificial intelligence (AI) technology is capable of accurately diagnosing COVID-19 in just a few minutes. More...
20 Jan 2022
Copyright © 2000-2022 Globetech Media. All rights reserved.